Latest News

Earlier today
Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors Medpage Today01:42
AI and Breast Cancer Screening; Cancer After Treatment for Sickle Cell Medpage Today01:42
Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer Medpage Today01:42
Yesterday
Navigating breast cancer decisions / Balancing personal choices and medical insights The Daily Star, Bangladesh13:49 9-Dec-23
Dr Ana Ferrigno Guajardo: Unanswered Questions About Taxane Chemotherapy Interventions During Pregnancy American Journal of Managed Care11:22 9-Dec-23
Dr Yadav Siddhartha: The Underutilization of BRCA Testing American Journal of Managed Care10:52 9-Dec-23
New TROPiCS-02 Data Back Sacituzumab Govitecan for Older Patients With Breast Cancer American Journal of Managed Care08:29 9-Dec-23
Five lesser-known warning signs of breast cancer other than finding a lump Chronicle Live08:20 9-Dec-23
Five lesser-known symptoms of breast cancer you should get checked Teesside Gazette04:45 9-Dec-23
Five lesser-known symptoms of breast cancer that aren't feeling a lump in chest The Mirror02:46 9-Dec-23
Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA? Medpage Today01:27 9-Dec-23
Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer Medpage Today01:27 9-Dec-23
Maintenance Pembrolizumab-Olaparib Fails to Boost Survival in TNBC Medpage Today01:27 9-Dec-23
In the last 7 days
Women over 50 can safely reduce mammogram frequency after breast cancer surgery News-Medical.Net23:48 8-Dec-23
Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds News-Medical.Net23:07 8-Dec-23
Study identifies targetable fusion RNAs in breast cancer News-Medical.Net20:35 8-Dec-23
Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer OncLive19:26 8-Dec-23
Neoadjuvant Nivolumab Plus Carboplatin/Paclitaxel Elicits High pCR Rates in Early-Stage TNBC OncLive18:45 8-Dec-23
Zanidatamab Triplet Shows Positive PFS Outcomes in HR+/HER2+ Metastatic Breast Cancer OncLive17:53 8-Dec-23
EFS Benefit With Neoadjuvant Pembrolizumab/Chemo Combo, Adjuvant Pembrolizumab Upheld in High-Risk Early TNBC OncLive17:43 8-Dec-23
Julia Bradbury had a mastectomy after her breast cancer diagnosis in 2021. Now she's joining a… Mail Online17:36 8-Dec-23
POSITIVE Trial Update on Patients With Breast Cancer Attempting Pregnancy American Journal of Managed Care17:03 8-Dec-23
MammaPrint Predicts Likelihood of pCR With Neoadjuvant Chemo in HR+/HER2– Early Breast Cancer OncLive16:52 8-Dec-23
Atezolizumab Plus Neoadjuvant HP/Chemo Does Not Significantly Improve pCR in HER2+ Breast Cancer OncLive16:42 8-Dec-23
Dr Gabriel Hortobagyi on NATALEE Trial Outcomes and Future Research Directions American Journal of Managed Care16:32 8-Dec-23
Adjuvant T-DM1 Provides Sustained Survival Benefit in HER2+ Early Breast Cancer OncLive16:21 8-Dec-23
No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens Pharmacy Times15:28 8-Dec-23
Obesity May Contribute to Biological Differences in Breast Cancer Tumors OncLive15:20 8-Dec-23
Elacestrant Improves PFS in ESR1-Mutant Metastatic Breast Cancer Subgroups OncLive14:19 8-Dec-23
Ribociclib Plus Nonsteroidal Aromatase Inhibitor Improves iDFS in HR+ HER2- Early Breast Cancer OncLive14:09 8-Dec-23
City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast… Business Wire (Press Release)13:32 8-Dec-23
Study Reinforces Safety of Taxane-Based Chemotherapies for Pregnant Patients With Breast Cancer Pharmacy Times13:27 8-Dec-23
Jazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of… PR Newswire (Press Release)13:24 8-Dec-23
Ribometrix Demonstrates Rapid Progress for eIF4E Program at San Antonio Breast Cancer Symposium Business Wire (Press Release)13:09 8-Dec-23
SIM0270 Demonstrates Early Antitumor Activity in ER+/HER2– Advanced/Metastatic Breast Cancer OncLive12:48 8-Dec-23
The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects Pharmacy Times12:05 8-Dec-23
Roche's Kadcyla is the first targeted therapy to show significant overall survival benefit in people with HER2-positive … GlobeNewswire (Press Release)11:54 8-Dec-23
Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone… GlobeNewswire (Press Release)11:49 8-Dec-23
Genentech’s Inavolisib Combination Reduces the Risk of Disease Progression by 57% in People… Business Wire (Press Release)11:47 8-Dec-23
‘SUCH KINDNESS’: Sabina Higgins thanks public for support following breast cancer diagnosis The Irish Post11:38 8-Dec-23
'Fantastic news': Mum cancer-free after international medical trial New Zealand Herald11:12 8-Dec-23
Shoulder to shoulder Novartis (Press Release)10:04 8-Dec-23
HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the… Nature.com09:34 8-Dec-23
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of… GlobeNewswire (Press Release)09:16 8-Dec-23
Expert: Pharmacists Play Key Role in Culturally Competent Care for Racially Diverse Patients Pharmacy Times09:13 8-Dec-23
Women With Very Early Breast Cancer May Safely Skip Radiation Rx: Study U.S. News & World Report08:57 8-Dec-23
Can Breast Cancer Survivors Reduce Frequency of Mammograms? U.S. News & World Report08:57 8-Dec-23
Lymphedema Left her 'Miserable, Depressed' Until Specialized Surgery Changed Everything U.S. News & World Report08:57 8-Dec-23
Some Early Breast Cancer Patients Can Skip Radiation NewsMax08:44 8-Dec-23
One genetic mutation may be responsible for 20% of severe breast cancer cases Study Finds08:34 8-Dec-23
Breast cancer survivors may not need so many mammograms after surgery, UK study suggests Mail Online08:31 8-Dec-23
Intensity Therapeutics Presents Positive INT230-6 Data in Patients with Early-Stage Breast… PR Newswire (Press Release)08:31 8-Dec-23
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of… Business Wire (Press Release)08:07 8-Dec-23
Cruk Media volunteer award for Luton cancer survivor and author Denise Coates Luton Today08:01 8-Dec-23
Exercise can improve metastatic breast cancer patients' quality of life, study finds PhillyVoice06:39 8-Dec-23
An end to breast cancer? California company develops groundbreaking vaccine with promising future CBS News04:31 8-Dec-23
Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast Cancer Medpage Today02:02 8-Dec-23
No Benefit to Adjuvant-Only Immunotherapy in Early TNBC Medpage Today02:02 8-Dec-23
Inavolisib Plus Palbociclib and Fulvestrant Improves PFS in PIK3CA-Mutated HR+ Breast Cancer OncLive22:34 7-Dec-23
Flaxseed lignans found to influence gut microbiome and breast cancer risk News-Medical.Net22:13 7-Dec-23
Anastrozole efficacy in breast cancer prevention for high-risk women linked to estrogen levels News-Medical.Net21:33 7-Dec-23
Trastuzumab Deruxtecan Plus Endocrine Therapy Demonstrates Antitumor Activity in HER2-Low/HR+ Metastatic Breast Cancer OncLive17:59 7-Dec-23
T-DXd Yields Early Activity in HER2+/HER2-Low Breast Cancer With Leptomeningeal Carcinomatosis OncLive17:59 7-Dec-23
Manipulation of gut microbiota with flaxseed could reduce breast cancer risk Newswise (Press Release)17:55 7-Dec-23
Early life gene epimutation may cause breast cancer. Newswise (Press Release)17:45 7-Dec-23
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities American Journal of Managed Care17:28 7-Dec-23
Martina Navratilova opens up on her 'stay away' strategy after being terrified by cancer Daily and Sunday Express17:03 7-Dec-23
Datopotamab Deruxtecan Prolongs PFS in HR+/HER2- Inoperable or Metastatic Breast Cancer OncLive15:37 7-Dec-23
T-DXd Demonstrates Real-World Efficacy in Advanced Breast Cancer With Dynamic HER2 Expression OncLive14:46 7-Dec-23
Study finds link between epimutations in BRCA1 gene and triple-negative breast cancer risk News-Medical.Net14:35 7-Dec-23
Expert: Evolution of Management of Breast Cancer has "Undergone Profound Changes" Pharmacy Times14:34 7-Dec-23
IDEA trial: Skipping radiotherapy safe for younger postmenopausal patients with early-stage breast cancer News-Medical.Net14:25 7-Dec-23
Exercise may become part of standard treatment for metastatic breast cancer, study suggests News-Medical.Net14:15 7-Dec-23
Refining Precision Prevention for Benign Breast Disease American Journal of Managed Care13:55 7-Dec-23
Dantari’s polymer nanoparticle-drug conjugate clears PhI breast cancer hurdle, sparking PhII plans ENDPOINTS13:21 7-Dec-23
MBrace Therapeutics Presents Preclinical Data Demonstrating Potential of Novel Antibody Drug… Business Wire (Press Release)13:02 7-Dec-23
Dantari's Novel High-Capacity Drug Conjugate DAN-222 Shows Promising Antitumor Activity in… PR Newswire (Press Release)13:01 7-Dec-23
Dr Kelly-Anne Phillips Discusses Hormonal Contraceptives, BRCA Mutations, and Breast Cancer Risk American Journal of Managed Care12:54 7-Dec-23
Pfizer and Arvinas plan vepdegestrant programme expansion after data at SABCS Pharmaceutical Technology12:31 7-Dec-23
Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast… Pharmacy Times11:30 7-Dec-23
Adding Pembrolizumab to Chemotherapy Increased Pathological Complete Response, Improved Residual Cancer Burden in… Pharmacy Times11:20 7-Dec-23
Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities Newswise (Press Release)11:06 7-Dec-23
Abemaciclib, Nonsteroidal Aromatase Inhibitor Extends Overall Survival for Patients With HR+, HER2- Advanced Breast… Pharmacy Times10:50 7-Dec-23
Flaxseeds may reduce risk of breast Cancer, study suggests Mail Online10:39 7-Dec-23
Two Leading Breast Cancer Organizations Join Forces to Save Lives Through Early Detection Business Wire (Press Release)10:14 7-Dec-23
Some Older Women With Early-Stage Breast Cancer Can Safely Skip Radiotherapy: Study U.S. News & World Report10:05 7-Dec-23
Pausing Endocrine Therapy for Pregnancy Did Not Increase Risk of Recurrence for Those With HR+ Breast Cancer Pharmacy Times09:29 7-Dec-23
Dr Sara Hurvitz: Addition of Tucatinib to T-DM1 Improves Outcomes in HER2+ Metastatic Breast Cancer American Journal of Managed Care09:20 7-Dec-23
Exercise Brings Better Quality of Life to Women With Advanced Breast Cancer U.S. News & World Report08:52 7-Dec-23
Roche shares positive late-stage results for inavolisib combination in advanced breast cancer PMLiVE07:23 7-Dec-23
Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS PR Newswire (Press Release)07:03 7-Dec-23
Linda Nolan issues health battle update after incurable breast cancer diagnosis Daily Star05:21 7-Dec-23
Linda Nolan, 64, reveals she is 'ready for a knees-up and to enjoy Christmas' after learning… Mail Online05:03 7-Dec-23
Remarkable new approach lets breast cancer patients avoid radiotherapy WA Today03:01 7-Dec-23
Tucatinib Regimen Boosts PFS in Advanced HER2-Positive Breast Cancer Medpage Today01:27 7-Dec-23
Clinical Challenges: Optimizing Locoregional Therapy in Older Breast Cancer Patients Medpage Today01:27 7-Dec-23
AI aids in early detection of breast cancer News-Medical.Net00:01 7-Dec-23
Disparities in Survival Outcomes Revealed With BluePrint and MammaPrint Subtyping in HR+/HER2– Breast Cancer OncLive20:16 6-Dec-23
Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast… PR Newswire (Press Release)18:08 6-Dec-23
BDC-1001 Plus Pertuzumab Is Under Exploration in HER2+ Breast Cancer OncLive18:04 6-Dec-23
Exai Bio’s RNA- and AI-based Liquid Biopsy Platform Detects Early Stage Breast Cancer with High … Business Wire (Press Release)18:02 6-Dec-23
Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative… PR Newswire (Press Release)17:47 6-Dec-23
PFS Benefit Observed With Tucatinib Plus T-DM1 in Previously Treated HER2+ Metastatic Breast Cancer OncLive17:44 6-Dec-23
Maintenance Pembrolizumab/Olaparib Misses Survival End Points in Locally Advanced or Metastatic TNBC OncLive17:34 6-Dec-23
Susan G. Komen® Awardees Recognized at San Antonio Breast Cancer Research Symposium Newswise (Press Release)16:11 6-Dec-23
Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from… PR Newswire (Press Release)16:06 6-Dec-23
Neoadjuvant Pembrolizumab Plus Chemo Improves pCR Across Key ER+ Breast Cancer Subgroups OncLive16:02 6-Dec-23
Susan G. Komen® Breast Cancer Research Awards Presented To Exceptional Breast Cancer Physician… PR Newswire (Press Release)16:01 6-Dec-23
Persistent ctDNA Correlates With Disease Recurrence in HR+/HER2– Early Breast Cancer OncLive15:21 6-Dec-23
Study: Patients With PD-L1-Positive, High-Risk, ER+/HER2- Breast Cancer Can Achieve Substantial Complete Response Rates … Pharmacy Times15:01 6-Dec-23
Capivasertib Maintains QOL Benefit Vs Placebo in HR+/HER2– Advanced Breast Cancer OncLive14:41 6-Dec-23
AI Assistance Proves Safe, Decreases Time and Cost Burden of Sentinel Lymph Node Detection in Metastatic Breast Cancer OncLive13:50 6-Dec-23
DB-1310 by Duality Biologics (Shanghai) for Human Epidermal Growth Factor Receptor 2 Positive… Pharmaceutical Technology13:26 6-Dec-23
Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer News-Medical.Net13:10 6-Dec-23
ORB-011 by Orionis Biosciences for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval Pharmaceutical Technology13:05 6-Dec-23

      
            
      
    view more headlines
   
      
      
      
10 Dec 01:42
   

Breast Cancer

Latest News

Cancer Top Stories

Health Top Stories

Lifestyle Top Stories